Live

Mitochondria, potential new therapeutic targets in pancreatic cancer -

Sep 2019 Oncotarget

Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.

Authors

Chretien AS, Fauriat C, Orlanducci F, Rey J, Gautherot E, Granjeaud S, Demerle C, Hamel JF, Cerwenka A, von Strandmann EP, Ifrah N, Lacombe C, Cornillet-Lefebvre P, Delaunay J, Toubert A, Arnoulet C, Vey N, Olive D

Summary

[This corrects the article DOI: 10.18632/oncotarget.17747.].

Read the article